no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy
|
Li, Yenan |
|
2009 |
88 |
11 |
p. 1069-1077 |
article |
2 |
A novel mutation of −50 (G→A) in the direct repeat element of the β-globin gene identified in a patient with severe β-thalassemia
|
Li, Dong-Zhi |
|
2009 |
88 |
11 |
p. 1149-1150 |
article |
3 |
Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system
|
Lösler, Susan |
|
2009 |
88 |
11 |
p. 1047-1058 |
article |
4 |
Cutaneous involvement in multiple myeloma and bortezomib
|
Siniscalchi, A. |
|
2009 |
88 |
11 |
p. 1137-1139 |
article |
5 |
Diagnostic complication and molecular characteristics of Hb SC-Chicago disease with α-thal-2 (-α3.7 deletion): effects of multiple variant on patient’s phenotype
|
Hughes, Heather Yaun |
|
2009 |
88 |
11 |
p. 1151-1153 |
article |
6 |
Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway
|
Koh, Youngil |
|
2009 |
88 |
11 |
p. 1089-1097 |
article |
7 |
Diversity in clinical presentation of hemoglobin H disease induced by the SEA deletion and the hemoglobin Quong Sze
|
Liao, Can |
|
2009 |
88 |
11 |
p. 1145-1147 |
article |
8 |
DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma
|
Kropff, Martin |
|
2009 |
88 |
11 |
p. 1125-1130 |
article |
9 |
Durable response to a single dose of Anti D in immune thrombocytopenic purpura in an adult with underlying human immunodeficiency viral infection
|
Hewamana, Saman |
|
2009 |
88 |
11 |
p. 1155-1156 |
article |
10 |
Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens
|
Kim, Sang-Ki |
|
2009 |
88 |
11 |
p. 1113-1123 |
article |
11 |
Intermediate dose gemcitabine–cisplatin combination chemotherapy without treatment delay for cytopenia followed by autografting—a new standard of care in relapsed or refractory Hodgkin lymphoma?
|
Todd, T. |
|
2009 |
88 |
11 |
p. 1107-1112 |
article |
12 |
Isoderivative of deleted chromosome 20 in primary myelofibrosis (PMF) characterized by molecular cytogenetics and array CGH
|
Douet-Guilbert, N. |
|
2009 |
88 |
11 |
p. 1157-1159 |
article |
13 |
Opposite expression pattern of Src kinase Lyn in acute and chronic haematological malignancies
|
Hussein, Kais |
|
2009 |
88 |
11 |
p. 1059-1067 |
article |
14 |
Repeated responses of an elderly patient with high-risk myelodysplastic syndrome to sequential therapy with tipifarnib, 5-azacitidine, and decitabine
|
Möller, Isabel |
|
2009 |
88 |
11 |
p. 1141-1144 |
article |
15 |
Risk factors for leukemia in Thailand
|
Kaufman, David W. |
|
2009 |
88 |
11 |
p. 1079-1088 |
article |
16 |
Serum ferritin concentrations in Africans with low dietary iron
|
Moyo, Victor M. |
|
2009 |
88 |
11 |
p. 1131-1136 |
article |
17 |
Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea
|
Choi, Moon Ki |
|
2009 |
88 |
11 |
p. 1099-1106 |
article |